标题
Dendritic cell-based immunotherapy
作者
关键词
-
出版物
CELL RESEARCH
Volume 27, Issue 1, Pages 74-95
出版商
Springer Nature
发表日期
2016-12-27
DOI
10.1038/cr.2016.157
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Transcriptional Control of Dendritic Cell Development
- (2016) Theresa L. Murphy et al. Annual Review of Immunology
- Critical Role for CD103 + /CD141 + Dendritic Cells Bearing CCR7 for Tumor Antigen Trafficking and Priming of T Cell Immunity in Melanoma
- (2016) Edward W. Roberts et al. CANCER CELL
- Prophylactic vaccines are potent activators of monocyte-derived dendritic cells and drive effective anti-tumor responses in melanoma patients at the cost of toxicity
- (2016) Kalijn F. Bol et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma
- (2016) Willy Hugo et al. CELL
- Expansion and Activation of CD103 + Dendritic Cell Progenitors at the Tumor Site Enhances Tumor Responses to Therapeutic PD-L1 and BRAF Inhibition
- (2016) Hélène Salmon et al. IMMUNITY
- Phase II Study of Autologous Monocyte-Derived mRNA Electroporated Dendritic Cells (TriMixDC-MEL) Plus Ipilimumab in Patients With Pretreated Advanced Melanoma
- (2016) Sofie Wilgenhof et al. JOURNAL OF CLINICAL ONCOLOGY
- Comparative genomics analysis of mononuclear phagocyte subsets confirms homology between lymphoid tissue-resident and dermal XCR1+ DCs in mouse and human and distinguishes them from Langerhans cells
- (2016) Sabrina Carpentier et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Visualization of immediate immune responses to pioneer metastatic cells in the lung
- (2016) Mark B. Headley et al. NATURE
- Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy
- (2016) Lena M. Kranz et al. NATURE
- Antitumor dendritic cell–based vaccines: lessons from 20 years of clinical trials and future perspectives
- (2016) João Constantino et al. Translational Research
- CD4 Receptor is a Key Determinant of Divergent HIV-1 Sensing by Plasmacytoid Dendritic Cells
- (2016) Meagan O’Brien et al. PLoS Pathogens
- The Dendritic Cell Synapse: A Life Dedicated to T Cell Activation
- (2016) Federica Benvenuti Frontiers in Immunology
- Efficacy and safety of CDX-301, recombinant human Flt3L, at expanding dendritic cells and hematopoietic stem cells in healthy human volunteers
- (2015) N Anandasabapathy et al. BONE MARROW TRANSPLANTATION
- Oncolytic viruses: focusing on the tumor microenvironment
- (2015) C R de Vries et al. CANCER GENE THERAPY
- Citrullinated Vimentin Presented on MHC-II in Tumor Cells Is a Target for CD4+ T-Cell-Mediated Antitumor Immunity
- (2015) V. A. Brentville et al. CANCER RESEARCH
- Molecular and Genetic Properties of Tumors Associated with Local Immune Cytolytic Activity
- (2015) Michael S. Rooney et al. CELL
- Humoral Immune Response against Nontargeted Tumor Antigens after Treatment with Sipuleucel-T and Its Association with Improved Clinical Outcome
- (2015) D. GuhaThakurta et al. CLINICAL CANCER RESEARCH
- Effective Clinical Responses in Metastatic Melanoma Patients after Vaccination with Primary Myeloid Dendritic Cells
- (2015) G. Schreibelt et al. CLINICAL CANCER RESEARCH
- Structural and agonist properties of XCL2, the other member of the C-chemokine subfamily
- (2015) Jamie C. Fox et al. CYTOKINE
- Antibodies targeting Clec9A promote strong humoral immunity without adjuvant in mice and non-human primates
- (2015) Jessica Li et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Lentivirus-induced ‘Smart’ dendritic cells: Pharmacodynamics and GMP-compliant production for immunotherapy against TRP2-positive melanoma
- (2015) B S Sundarasetty et al. GENE THERAPY
- Strategically Localized Dendritic Cells Promote Rapid T Cell Responses to Lymph-Borne Particulate Antigens
- (2015) Michael Y. Gerner et al. IMMUNITY
- Lentiviral vectors in cancer immunotherapy
- (2015) Robyn AA Oldham et al. Immunotherapy
- Oncolytic Virus-Mediated Immunotherapy: A Combinatorial Approach for Cancer Treatment
- (2015) Sean E. Lawler et al. JOURNAL OF CLINICAL ONCOLOGY
- Safety and Survival With GVAX Pancreas Prime and Listeria Monocytogenes–Expressing Mesothelin (CRS-207) Boost Vaccines for Metastatic Pancreatic Cancer
- (2015) Dung T. Le et al. JOURNAL OF CLINICAL ONCOLOGY
- Restricted dendritic cell and monocyte progenitors in human cord blood and bone marrow
- (2015) Jaeyop Lee et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Circulating precursors of human CD1c+and CD141+dendritic cells
- (2015) Gaëlle Breton et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Clonal analysis of human dendritic cell progenitor using a stromal cell culture
- (2015) Jaeyop Lee et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Targeting Antigen to Clec9A Primes Follicular Th Cell Memory Responses Capable of Robust Recall
- (2015) Yu Kato et al. JOURNAL OF IMMUNOLOGY
- Laser-Assisted Intradermal Delivery of Adjuvant-Free Vaccines Targeting XCR1+Dendritic Cells Induces Potent Antitumoral Responses
- (2015) Dorothea Terhorst et al. JOURNAL OF IMMUNOLOGY
- Tetanus toxoid and CCL3 improve dendritic cell vaccines in mice and glioblastoma patients
- (2015) Duane A. Mitchell et al. NATURE
- Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity
- (2015) Stefani Spranger et al. NATURE
- Identification of cDC1- and cDC2-committed DC progenitors reveals early lineage priming at the common DC progenitor stage in the bone marrow
- (2015) Andreas Schlitzer et al. NATURE IMMUNOLOGY
- Defining human dendritic cell progenitors by multiparametric flow cytometry
- (2015) Gaëlle Breton et al. Nature Protocols
- Genomic correlates of response to CTLA-4 blockade in metastatic melanoma
- (2015) E. M. Van Allen et al. SCIENCE
- Neoantigens in cancer immunotherapy
- (2015) T. N. Schumacher et al. SCIENCE
- A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells
- (2015) B. M. Carreno et al. SCIENCE
- Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer
- (2015) N. A. Rizvi et al. SCIENCE
- Vaccines, Adjuvants, and Dendritic Cell Activators—Current Status and Future Challenges
- (2015) Joseph Obeid et al. SEMINARS IN ONCOLOGY
- Antigenically Modified Human Pluripotent Stem Cells Generate Antigen-Presenting Dendritic Cells
- (2015) Jieming Zeng et al. Scientific Reports
- Umbilical cord blood-derived CD11c+ dendritic cells could serve as an alternative allogeneic source of dendritic cells for cancer immunotherapy
- (2015) Jeetendra Kumar et al. Stem Cell Research & Therapy
- Direct Activation of STING in the Tumor Microenvironment Leads to Potent and Systemic Tumor Regression and Immunity
- (2015) Leticia Corrales et al. Cell Reports
- Induction of T-cell Immunity Overcomes Complete Resistance to PD-1 and CTLA-4 Blockade and Improves Survival in Pancreatic Carcinoma
- (2015) R. Winograd et al. Cancer Immunology Research
- First oncolytic virus approved for melanoma immunotherapy
- (2015) Jonathan Pol et al. OncoImmunology
- Survival with AGS-003, an autologous dendritic cell–based immunotherapy, in combination with sunitinib in unfavorable risk patients with advanced renal cell carcinoma (RCC): Phase 2 study results
- (2015) Asim Amin et al. Journal for ImmunoTherapy of Cancer
- TLR Signals Induce Phagosomal MHC-I Delivery from the Endosomal Recycling Compartment to Allow Cross-Presentation
- (2014) Priyanka Nair-Gupta et al. CELL
- Comparison of media and serum supplementation for generation of monophosphoryl lipid A/interferon-γ–matured type I dendritic cells for immunotherapy
- (2014) Sonja T.H.M. Kolanowski et al. CYTOTHERAPY
- Vaccine molecules targeting Xcr1 on cross-presenting DCs induce protective CD8+T-cell responses against influenza virus
- (2014) Even Fossum et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Neo-antigens predicted by tumor genome meta-analysis correlate with increased patient survival
- (2014) S. D. Brown et al. GENOME RESEARCH
- Human Dermal CD14 + Cells Are a Transient Population of Monocyte-Derived Macrophages
- (2014) Naomi McGovern et al. IMMUNITY
- Vaccination of a Melanoma Patient with Mature Dendritic Cells Pulsed with MAGE-3 Peptides Triggers the Activity of Nonvaccine Anti-Tumor Cells
- (2014) J. Carrasco et al. JOURNAL OF IMMUNOLOGY
- Induction of Potent CD8 T Cell Cytotoxicity by Specific Targeting of Antigen to Cross-Presenting Dendritic Cells In Vivo via Murine or Human XCR1
- (2014) Evelyn Hartung et al. JOURNAL OF IMMUNOLOGY
- High-throughput epitope discovery reveals frequent recognition of neo-antigens by CD4+ T cells in human melanoma
- (2014) Carsten Linnemann et al. NATURE MEDICINE
- Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma
- (2014) Alexandra Snyder et al. NEW ENGLAND JOURNAL OF MEDICINE
- Immune Activation and a 9-Year Ongoing Complete Remission Following CD40 Antibody Therapy and Metastasectomy in a Patient with Metastatic Melanoma
- (2014) D. L. Bajor et al. Cancer Immunology Research
- Immunotherapy Converts Nonimmunogenic Pancreatic Tumors into Immunogenic Foci of Immune Regulation
- (2014) E. R. Lutz et al. Cancer Immunology Research
- Therapeutic In Situ Autovaccination against Solid Cancers with Intratumoral Poly-ICLC: Case Report, Hypothesis, and Clinical Trial
- (2014) A. M. Salazar et al. Cancer Immunology Research
- Dendritic cells derived from pluripotent stem cells: Potential of large scale production
- (2014) Yan Li World Journal of Stem Cells
- The Dendritic Cell Lineage: Ontogeny and Function of Dendritic Cells and Their Subsets in the Steady State and the Inflamed Setting
- (2013) Miriam Merad et al. Annual Review of Immunology
- Pathways of Antigen Processing
- (2013) Janice S. Blum et al. Annual Review of Immunology
- CD141+ dendritic cells produce prominent amounts of IFN- after dsRNA recognition and can be targeted via DEC-205 in humanized mice
- (2013) S. Meixlsperger et al. BLOOD
- Natural Human Plasmacytoid Dendritic Cells Induce Antigen-Specific T-Cell Responses in Melanoma Patients
- (2013) J. Tel et al. CANCER RESEARCH
- Targeting of 111In-Labeled Dendritic Cell Human Vaccines Improved by Reducing Number of Cells
- (2013) E. H. J. G. Aarntzen et al. CLINICAL CANCER RESEARCH
- A Dendritic Cell Vaccine Pulsed with Autologous Hypochlorous Acid-Oxidized Ovarian Cancer Lysate Primes Effective Broad Antitumor Immunity: From Bench to Bedside
- (2013) C. L.-L. Chiang et al. CLINICAL CANCER RESEARCH
- A Phase I Study of an Agonist CD40 Monoclonal Antibody (CP-870,893) in Combination with Gemcitabine in Patients with Advanced Pancreatic Ductal Adenocarcinoma
- (2013) G. L. Beatty et al. CLINICAL CANCER RESEARCH
- Human dendritic cell subsets
- (2013) Matthew Collin et al. IMMUNOLOGY
- IL-12p70–producing patient DC vaccine elicits Tc1-polarized immunity
- (2013) Beatriz M. Carreno et al. JOURNAL OF CLINICAL INVESTIGATION
- Antigen delivery to early endosomes eliminates the superiority of human blood BDCA3+dendritic cells at cross presentation
- (2013) Lillian Cohn et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Transcriptional Profiling of Human Dendritic Cell Populations and Models - Unique Profiles of In Vitro Dendritic Cells and Implications on Functionality and Applicability
- (2013) Kristina Lundberg et al. PLoS One
- MHC Class I-Associated Phosphopeptides Are the Targets of Memory-like Immunity in Leukemia
- (2013) M. Cobbold et al. Science Translational Medicine
- Inflammatory dendritic cells in mice and humans
- (2013) Elodie Segura et al. TRENDS IN IMMUNOLOGY
- Allogeneic partially HLA-matched dendritic cells pulsed with autologous tumor cell lysate as a vaccine in metastatic renal cell cancer
- (2013) Anne Flörcken et al. Human Vaccines & Immunotherapeutics
- The Dendritic Cell Response to Classic, Emerging, and Homeostatic Danger Signals. Implications for Autoimmunity
- (2013) Paul M. Gallo et al. Frontiers in Immunology
- Decisions About Dendritic Cells: Past, Present, and Future
- (2012) Ralph M. Steinman Annual Review of Immunology
- Human plasmacytoid dendritic cells efficiently cross-present exogenous Ags to CD8+ T cells despite lower Ag uptake than myeloid dendritic cell subsets
- (2012) J. Tel et al. BLOOD
- HER-2 pulsed dendritic cell vaccine can eliminate HER-2 expression and impact ductal carcinoma in situ
- (2012) Anupama Sharma et al. CANCER
- A placebo-controlled randomized HPV16 synthetic long-peptide vaccination study in women with high-grade cervical squamous intraepithelial lesions
- (2012) Peggy J. de Vos van Steenwijk et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Sipuleucel-T immune parameters correlate with survival: an analysis of the randomized phase 3 clinical trials in men with castration-resistant prostate cancer
- (2012) Nadeem A. Sheikh et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Phase I Trial of Overlapping Long Peptides from a Tumor Self-Antigen and Poly-ICLC Shows Rapid Induction of Integrated Immune Response in Ovarian Cancer Patients
- (2012) P. Sabbatini et al. CLINICAL CANCER RESEARCH
- Human Type 2 Myeloid Dendritic Cells Produce Interferon-λ and Amplify Interferon-α in Response to Hepatitis C Virus Infection
- (2012) Shuye Zhang et al. GASTROENTEROLOGY
- Efficient transduction of myeloid cells by an HIV-1-derived lentiviral vector that packages the Vpx accessory protein
- (2012) S Bobadilla et al. GENE THERAPY
- Human Tissues Contain CD141hi Cross-Presenting Dendritic Cells with Functional Homology to Mouse CD103+ Nonlymphoid Dendritic Cells
- (2012) Muzlifah Haniffa et al. IMMUNITY
- Addition of interferon-α to the p53-SLP® vaccine results in increased production of interferon-γ in vaccinated colorectal cancer patients: A phase I/II clinical trial
- (2012) Eliane C.M. Zeestraten et al. INTERNATIONAL JOURNAL OF CANCER
- HIV-1 infection–induced apoptotic microparticles inhibit human DCs via CD44
- (2012) Davor Frleta et al. JOURNAL OF CLINICAL INVESTIGATION
- Clinical Trial of the Intratumoral Administration of Labeled DC Combined With Systemic Chemotherapy for Esophageal Cancer
- (2012) Shinichi Fujiwara et al. JOURNAL OF IMMUNOTHERAPY
- Prime-boost regimens with adjuvanted synthetic long peptides elicit T cells and antibodies to conserved regions of HIV-1 in macaques
- (2011) Maximillian Rosario et al. AIDS
- Peptide-Loaded Langerhans Cells, Despite Increased IL15 Secretion and T-Cell Activation In Vitro, Elicit Antitumor T-Cell Responses Comparable to Peptide-Loaded Monocyte-Derived Dendritic Cells In Vivo
- (2011) E. Romano et al. CLINICAL CANCER RESEARCH
- Route of Administration Modulates the Induction of Dendritic Cell Vaccine-Induced Antigen-Specific T Cells in Advanced Melanoma Patients
- (2011) W. J. Lesterhuis et al. CLINICAL CANCER RESEARCH
- A new synthetic TLR4 agonist, GLA, allows dendritic cells targeted with antigen to elicit Th1 T-cell immunity in vivo
- (2011) Austin Pantel et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Virus-induced tumor inflammation facilitates effective DC cancer immunotherapy in a Treg-dependent manner in mice
- (2011) Norman Woller et al. JOURNAL OF CLINICAL INVESTIGATION
- Targeting Antigen to Mouse Dendritic Cells via Clec9A Induces Potent CD4 T Cell Responses Biased toward a Follicular Helper Phenotype
- (2011) M. H. Lahoud et al. JOURNAL OF IMMUNOLOGY
- Dendritic cell-targeted protein vaccines: a novel approach to induce T-cell immunity
- (2011) C. Trumpfheller et al. JOURNAL OF INTERNAL MEDICINE
- Dendritic Cell Based Tumor Vaccination in Prostate and Renal Cell Cancer: A Systematic Review and Meta-Analysis
- (2011) Andreas Draube et al. PLoS One
- Comparable T helper 1 (Th1) and CD8 T-cell immunity by targeting HIV gag p24 to CD8 dendritic cells within antibodies to Langerin, DEC205, and Clec9A
- (2011) J. Idoyaga et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- How vitamin A metabolizing dendritic cells are generated in the gut mucosa
- (2011) William W. Agace et al. TRENDS IN IMMUNOLOGY
- Conservation of a chemokine system, XCR1 and its ligand, XCL1, between human and mice
- (2010) Chihiro Yamazaki et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Commonly used prophylactic vaccines as an alternative for synthetically produced TLR ligands to mature monocyte-derived dendritic cells
- (2010) G. Schreibelt et al. BLOOD
- Vaccination with dendritic cell/tumor fusion cells results in cellular and humoral antitumor immune responses in patients with multiple myeloma
- (2010) J. Rosenblatt et al. BLOOD
- Improved cellular and humoral immune responses in vivo following targeting of HIV Gag to dendritic cells within human anti-human DEC205 monoclonal antibody
- (2010) C. Cheong et al. BLOOD
- Origin and development of dendritic cells
- (2010) Kang Liu et al. IMMUNOLOGICAL REVIEWS
- Pluripotent stem cells as source of dendritic cells for immune therapy
- (2010) Satoru Senju et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- In Situ Vaccination With a TLR9 Agonist Induces Systemic Lymphoma Regression: A Phase I/II Study
- (2010) Joshua D. Brody et al. JOURNAL OF CLINICAL ONCOLOGY
- Induction of CD8+ T-Cell Responses Against Novel Glioma–Associated Antigen Peptides and Clinical Activity by Vaccinations With α-Type 1 Polarized Dendritic Cells and Polyinosinic-Polycytidylic Acid Stabilized by Lysine and Carboxymethylcellulose in Patients With Recurrent Malignant Glioma
- (2010) Hideho Okada et al. JOURNAL OF CLINICAL ONCOLOGY
- Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
- (2010) Philip W. Kantoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- CD8+ T Cell Priming by Dendritic Cell Vaccines Requires Antigen Transfer to Endogenous Antigen Presenting Cells
- (2010) Alice W. Yewdall et al. PLoS One
- Metastatic tumour cells favour the generation of a tolerogenic milieu in tumour draining lymph node in patients with early cervical cancer
- (2009) Alessandra Battaglia et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Cytokine gene-mediated immunotherapy: Current status and future perspectives
- (2009) Masahisa Jinushi et al. CANCER SCIENCE
- Limited Amounts of Dendritic Cells Migrate into the T-Cell Area of Lymph Nodes but Have High Immune Activating Potential in Melanoma Patients
- (2009) P. Verdijk et al. CLINICAL CANCER RESEARCH
- Induction of p53-Specific Immunity by a p53 Synthetic Long Peptide Vaccine in Patients Treated for Metastatic Colorectal Cancer
- (2009) F. M. Speetjens et al. CLINICAL CANCER RESEARCH
- Immunologic activity and safety of autologous HIV RNA-electroporated dendritic cells in HIV-1 infected patients receiving antiretroviral therapy
- (2009) Jean-Pierre Routy et al. CLINICAL IMMUNOLOGY
- Sensing pathogens and danger signals by the inflammasome
- (2009) Joao HF Pedra et al. CURRENT OPINION IN IMMUNOLOGY
- Improving vaccines by targeting antigens to dendritic cells
- (2009) Ken Shortman et al. EXPERIMENTAL AND MOLECULAR MEDICINE
- Immunization with a P53 synthetic long peptide vaccine induces P53-specific immune responses in ovarian cancer patients, a phase II trial
- (2009) Ninke Leffers et al. INTERNATIONAL JOURNAL OF CANCER
- Phase Ib Trial Assessing Autologous, Tumor-pulsed Dendritic Cells as a Vaccine Administered With or Without IL-2 in Patients With Metastatic Melanoma
- (2009) Bruce G. Redman et al. JOURNAL OF IMMUNOTHERAPY
- Optimization of Dendritic Cell Loading With Tumor Cell Lysates for Cancer Immunotherapy
- (2009) Paul Hatfield et al. JOURNAL OF IMMUNOTHERAPY
- Adenovirus MART-1–engineered Autologous Dendritic Cell Vaccine for Metastatic Melanoma
- (2009) Lisa H. Butterfield et al. JOURNAL OF IMMUNOTHERAPY
- Human Papillomavirus Type 16 (HPV-16) Virus-Like Particle L1-Specific CD8+ Cytotoxic T Lymphocytes (CTLs) Are Equally Effective as E7-Specific CD8+ CTLs in Killing Autologous HPV-16-Positive Tumor Cells in Cervical Cancer Patients: Implications for L1 Dendritic Cell-Based Therapeutic Vaccines
- (2009) S. Bellone et al. JOURNAL OF VIROLOGY
- Spontaneous regression of metastases from melanoma: review of the literature
- (2009) Louise Vennegaard Kalialis et al. MELANOMA RESEARCH
- Identification of a dendritic cell receptor that couples sensing of necrosis to immunity
- (2009) David Sancho et al. NATURE
- Vaccination against HPV-16 Oncoproteins for Vulvar Intraepithelial Neoplasia
- (2009) Gemma G. Kenter et al. NEW ENGLAND JOURNAL OF MEDICINE
- Plasmacytoid Dendritic Cells Capture and Cross-Present Viral Antigens from Influenza-Virus Exposed Cells
- (2009) Gabrielle Lui et al. PLoS One
- The role of CD40 and CD154/CD40L in dendritic cells
- (2009) Daphne Y. Ma et al. SEMINARS IN IMMUNOLOGY
- A randomized therapeutic vaccine trial of canarypox-HIV-pulsed dendritic cells vs. canarypox-HIV alone in HIV-1-infected patients on antiretroviral therapy
- (2009) Rajesh T. Gandhi et al. VACCINE
- C-type lectins on dendritic cells: key modulators for the induction of immune responses
- (2008) Yvette van Kooyk BIOCHEMICAL SOCIETY TRANSACTIONS
- Prostaglandin E2 enhances T-cell proliferation by inducing the costimulatory molecules OX40L, CD70, and 4-1BBL on dendritic cells
- (2008) P. Krause et al. BLOOD
- Maturation of monocyte-derived dendritic cells with Toll-like receptor 3 and 7/8 ligands combined with prostaglandin E2 results in high interleukin-12 production and cell migration
- (2008) A. C. Inge Boullart et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- CD54 is a surrogate marker of antigen presenting cell activation
- (2008) N. A. Sheikh et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Dendritic cells dysfunction in tumour environment
- (2008) Karim Bennaceur et al. CANCER LETTERS
- Induction of Tumor-Specific CD4+ and CD8+ T-Cell Immunity in Cervical Cancer Patients by a Human Papillomavirus Type 16 E6 and E7 Long Peptides Vaccine
- (2008) M. J.P. Welters et al. CLINICAL CANCER RESEARCH
- Phase I Immunotherapeutic Trial with Long Peptides Spanning the E6 and E7 Sequences of High-Risk Human Papillomavirus 16 in End-Stage Cervical Cancer Patients Shows Low Toxicity and Robust Immunogenicity
- (2008) G. G. Kenter et al. CLINICAL CANCER RESEARCH
- Superior induction of anti-tumor CTL immunity by extended peptide vaccines involves prolonged, DC-focused antigen presentation
- (2008) Martijn S. Bijker et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Promises and challenges for the development ofListeria monocytogenes-based immunotherapies
- (2008) Dirk G Brockstedt et al. Expert Review of Vaccines
- Genetic engineering of T cells for adoptive immunotherapy
- (2008) Angel Varela-Rohena et al. IMMUNOLOGIC RESEARCH
- Enhancing the clinical activity of granulocyte-macrophage colony-stimulating factor-secreting tumor cell vaccines
- (2008) Masahisa Jinushi et al. IMMUNOLOGICAL REVIEWS
- CLEC9A Is a Novel Activation C-type Lectin-like Receptor Expressed on BDCA3+Dendritic Cells and a Subset of Monocytes
- (2008) Cristal Huysamen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Comparative evaluation of techniques for the manufacturing of dendritic cell-based cancer vaccines
- (2008) Alexander Michael Dohnal et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- KBMA Listeria monocytogenes is an effective vector for DC-mediated induction of antitumor immunity
- (2008) Mojca Skoberne et al. JOURNAL OF CLINICAL INVESTIGATION
- Small intestinal CD103+dendritic cells display unique functional properties that are conserved between mice and humans
- (2008) Elin Jaensson et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Suppressive Influences in the Immune Response to Cancer
- (2008) Vincenzo Bronte et al. JOURNAL OF IMMUNOTHERAPY
- Type 1-polarized dendritic cells loaded with autologous tumor are a potent immunogen against chronic lymphocytic leukemia
- (2008) Je-Jung Lee et al. JOURNAL OF LEUKOCYTE BIOLOGY
- The Foxp3+ regulatory T cell: a jack of all trades, master of regulation
- (2008) Qizhi Tang et al. NATURE IMMUNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now